404
Nootropics Market Analysis | 2024-2030
Nootropics Market Size, Share, Trends, Dynamics, Forecast, & Growth Analysis: 2024-2030
Nootropics Market is segmented by Drug Type (Prescription Nootropics [Modafinil, Adderall, Methylphenidate, Memantine], OTC Nootropics [Ginkgo Biloba, Panax Ginseng, Rhodiola Rosea, Nicotine, Others]), by Application (Memory Enhancement, Mood & Depression, Attention & Focus, Longevity & Anti-aging, Sleep & Recovery, Anxiety), by Distribution Channel (Offline, Online) and Region (North America, Europe, Asia-Pacific, and Rest of the World).
The report is delivered digitally through our online portal. Buyers receive login credentials from our team to access the report and may update their credentials at any time after the initial login.
Delivery timelines depend on the status of the report:
For the most accurate delivery timeline, please contact us to confirm the current status of the report.
Yes. You may request a complimentary preview of the report through a video conference with our team.
Yes. The scope of the report can be fully customized to align with your specific research objectives and information requirements.
Please contact us at [email protected], and our team will be happy to discuss your requirements and propose a tailored solution.
Yes. Selected sections of the report can be purchased separately based on your requirements. Please contact us at [email protected] to discuss your needs.
Yes, AI can help gather publicly available information, but its outputs are only as reliable as the data it accesses. Stratview Research reports are built using validated data, extensive primary interviews with industry stakeholders, and the expertise of our experienced research team.
Additionally, many critical insights, including market dynamics, competitive intelligence, and industry-specific trends, are not publicly available and therefore cannot be captured through AI alone.
Nootropics are drugs or supplements that are consumed by sportsmen and adults to enhance memory and other cognitive abilities. These are available in both OTC form and prescription drug type, wherein prescription nootropics are drugs that are used to treat diseases such as ‘attention deficit hyperactivity disorder’ (ADHD), Alzheimer’s disease, and narcolepsy. Whereas non-prescription drugs or OTC do not treat diseases but are consumed for improving brain performance and concentration capabilities.
The nootropics market was estimated at USD 3.7 billion in 2023.
The nootropics market is likely to reach USD 9.66 billion in 2030.
The nootropics market is likely to grow at a CAGR of 14.67% during 2024-2030.
Accelerated Intelligence Inc. (UK), AlternaScript (The U.S), HVMN (The U.S), Onnit Labs, Inc. (The U.S), Peak Nootropics (The U.S), Teva Pharmaceutical Industries (Israel), Purelife Bioscience Co., Ltd. (China), United Pharmacies (Moldova), SupNootropic bio co.,ltd (The U.S) and Powder City (The U.S) are among the top players in the market.
North America dominated the nootropics market in 2023 with an astounding share of more than 40% and is projected to grow at a healthy CAGR during the review period.
Increasing demand for smart drugs and brain boosters, continuous product development using both natural and synthetic raw materials, and the surge in the vegan population in developed countries of Europe and North America are the factors driving the growth of the market.
The online segment held a substantial market share in 2023 and is projected to register a robust CAGR of almost 14% during the review period.